P2.05. Prediction of Durable Response to Immunotherapy by Early Dynamic in ctDNA and Peripheral Immune Features in NSCLC - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Xinghao Ai
Meta Tag
Speaker Xinghao Ai
Topic Metastatic NSCLC: Immunotherapy - Biomarker
clinical trial
immune checkpoint inhibitors
non-small cell lung cancer
EGFR mutation
ALK mutation
circulating tumor DNA
peripheral blood mononuclear cells
RNA sequencing
Powered By